Proveca held their second paediatric educational meeting at the Birmingham Children’s Hospital on 4th of July. The programme was titled ‘Hypersalivation in Cerebral Palsy – A problem that should be taken seriously and licensed versus unlicensed medication in children.'
Professor Rajat Gupta, Lead Consultant in Paediatric Neurology, Birmingham Children’s Hospital, presented on Hypersalivation in Cerebral Palsy – A problem that should be taken seriously. Dr Helen Shaw, Medical Director, Proveca, gave an overview of the pan-European approach to licensing off-patent medicines in children, the Paediatric Use Marketing Authorisation (PUMA) and finally Mr Yusuf Asif, Clinical Formulary Pharmacist, Birmingham Children’s Hospital presented on licensed versus unlicensed medication in children. Dr Manjeet Raina, Consultant in Paediatric Neurodisability from Heartlands Birmingham Community Healthcare Trust chaired the meeting which was attended by many Paediatric Consultants from around Birmingham and the Midlands.
The meeting was an enormous success with excellent feedback including:
’Thorough discussion on drooling and impact on quality of patients’ lives and social status’
‘Helpful to know about pharmaceutical issues associated with unlicensed medications, very helpful, nice explanation why we should use licensed medicationss where possible’
'Clear and informative delivery of presentations from all 3 speakers'